News

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs ...
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
We are thrilled to welcome Jessica to the RAPT leadership team at this pivotal time for the company,” said Brian Wong, M.D., Ph.D., President and CEO of RAPT. “With her deep expertise as both an ...
Rapt Therapeutics appoints Jessica Savage as VP, clinical development
RAPT Therapeutics (RAPT) announced the appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development to oversee the ...
The American Journal of Managed Care5d
Challenges in Timely Identification of IgA Nephropathy
Panelists discuss how diagnostic challenges in immunoglobulin A (IgA) nephropathy lead to delayed identification, missed ...
The American Journal of Managed Care5d
Signs and Symptoms of IgA Nephropathy
Panelists discuss how patients with immunoglobulin A (IgA) nephropathy typically present with microscopic or gross hematuria, often during upper respiratory infections, along with variable proteinuria ...
Yahoo6d
Celebrating selflessness: Local organ transplant recipient to run in Gift of Life's Donor Dash
After a few more appointments and tests, it was discovered he was at 5% kidney function and diagnosed with IgA nephropathy, also known as Berger's disease, which is a chronic kidney disease ...
Travere Therapeutics price target lowered to $30 from $32 at Scotiabank
Scotiabank analyst Greg Harrison lowered the firm’s price target on Travere Therapeutics (TVTX) to $30 from $32 and keeps an ...